Dacarbazine, Cisplatin, and Interferon-Alfa-2b With or Without Interleukin-2 in Metastatic Melanoma: A Randomized Phase III Trial (18951) of the European Organisation for Research and Treatment of Cancer Melanoma Group - Concepedia

Concepedia

Publication | Open Access

Dacarbazine, Cisplatin, and Interferon-Alfa-2b With or Without Interleukin-2 in Metastatic Melanoma: A Randomized Phase III Trial (18951) of the European Organisation for Research and Treatment of Cancer Melanoma Group

DOI Full Paper Access

166

Citations

35

References

2005

Year

Ulrich Keilholz, Cornelis J.A. Punt, Martin Gore, Wim H.J. Kruit, Poulam Patel, Danielle Líénard, Jose Thomas, Thomas M. Proebstle, Alexander Schmittel, Dirk Schadendorf,

Journal of Clinical Oncology

Abstract

Despite its activity in melanoma as a single agent or in combination with interferon-alfa-2b, the chosen schedule of IL-2 added to the chemoimmunotherapy combination had no clinically relevant activity.

References

	Year	Citations

Page 1